In vitro activity of olorofim against clinical isolates of the Fusarium oxysporum and Fusarium solani species complexes.

The investigational agent olorofim demonstrated good in vitro activity against FOSC and FSSC clinical isolates. Further studies are warranted to determine how well this in vitro activity translates into in vivo efficacy.